Paul Lupo

Paul Lupo has a strong background in clinical operations and clinical trial management. Paul most recently served as the Director of Operations at PTC Therapeutics, Inc. since March 2020. Prior to that, they worked as the Associate Director of Clinical Operations at Prolong Pharmaceuticals from January 2019 to March 2020. Paul also has experience as a Protocol Manager at Bristol-Myers Squibb from April 2018 to January 2019 and as a Sr. Clinical Trial Lead (Associate Director) at Sandoz Inc. from April 2017 to February 2018. Before joining Sandoz Inc., they worked as a Clinical Trial Leader at Sandoz from December 2014 to April 2017. Paul started their career as a Sr. Clinical Development Scientist at Merck from April 2012 to December 2014.

Paul Lupo has a Bachelor of Science (B.Sc.) degree in Biology, General from Monmouth University.